155 related articles for article (PubMed ID: 16537031)
41. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.
Oliveira SC; Splitter GA
Vaccine; 1996 Jul; 14(10):959-62. PubMed ID: 8873388
[TBL] [Abstract][Full Text] [Related]
42. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
43. Brucella abortus L7/L12 recombinant protein induces strong Th1 response in acute brucellosis patients.
Kazak E; Oliveira SC; Goral G; Akalin H; Yilmaz E; Heper Y; Oral HB
Iran J Immunol; 2010 Sep; 7(3):132-41. PubMed ID: 20876984
[TBL] [Abstract][Full Text] [Related]
44. Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice.
Afley P; Dohre SK; Prasad GB; Kumar S
Appl Microbiol Biotechnol; 2015 Sep; 99(18):7625-37. PubMed ID: 26150246
[TBL] [Abstract][Full Text] [Related]
45. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
Yang X; Walters N; Robison A; Trunkle T; Pascual DW
Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of a DNA vaccine encoding Brucella BvrR in BALB/c mice.
Chen B; Liu B; Zhao Z; Wang G
Mol Med Rep; 2019 Feb; 19(2):1302-1308. PubMed ID: 30569140
[TBL] [Abstract][Full Text] [Related]
47. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
Commander NJ; Spencer SA; Wren BW; MacMillan AP
Vaccine; 2007 Jan; 25(1):43-54. PubMed ID: 17049676
[TBL] [Abstract][Full Text] [Related]
48. Comparative study of gamma interferon production in mice immunized with outer membrane proteins and whole bacteria of Brucella abortus.
Cha SB; Rayamajhi N; Kang ML; Lee WJ; Shin MK; Yoo HS
Jpn J Infect Dis; 2010 Jan; 63(1):49-51. PubMed ID: 20093762
[TBL] [Abstract][Full Text] [Related]
49. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
50. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis.
Ribeiro LA; Azevedo V; Le Loir Y; Oliveira SC; Dieye Y; Piard JC; Gruss A; Langella P
Appl Environ Microbiol; 2002 Feb; 68(2):910-6. PubMed ID: 11823235
[TBL] [Abstract][Full Text] [Related]
51. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
52. Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M.
Gupta VK; Rout PK; Vihan VS
Res Vet Sci; 2007 Jun; 82(3):305-13. PubMed ID: 17014873
[TBL] [Abstract][Full Text] [Related]
53. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
[TBL] [Abstract][Full Text] [Related]
54. Cloning, expression and immunogenicity of the translation initiation factor 3 homologue of Brucella abortus.
González M; Andrews E; Folch H; Sáez D; Cabrera A; Salgado P; Oñate A
Immunobiology; 2009; 214(2):113-20. PubMed ID: 19167989
[TBL] [Abstract][Full Text] [Related]
55. Immunogenicity and protective efficacy of DNA vaccines encoding MAP0586c and MAP4308c of Mycobacterium avium subsp. paratuberculosis secretome.
Roupie V; Leroy B; Rosseels V; Piersoel V; Noël-Georis I; Romano M; Govaerts M; Letesson JJ; Wattiez R; Huygen K
Vaccine; 2008 Sep; 26(37):4783-94. PubMed ID: 18652866
[TBL] [Abstract][Full Text] [Related]
56. [Construction of Brucella abortus A19-delta VirB12 mutant and evaluation of its protective efficacy against 2308 strain challenge in BALB/c mice].
Yi X; Ye F; Yao G; Gu W; Ma X; Wu D; Zhong Q
Wei Sheng Wu Xue Bao; 2013 Nov; 53(11):1213-20. PubMed ID: 24617263
[TBL] [Abstract][Full Text] [Related]
57. Protection of Brucella abortus RB51 revaccinated cows.
Blasco JM; Moriyon I
Comp Immunol Microbiol Infect Dis; 2005; 28(5-6):371-3; author reply 375-7. PubMed ID: 16182367
[No Abstract] [Full Text] [Related]
58. Evaluation of DNA vaccine encoding BCSP
Imtiaz W; Khan A; Gul ST; Saqib M; Saleemi MK; Shahzad A; Dong J; Hussain R; Shen M; Du X
Microb Pathog; 2018 Dec; 125():514-520. PubMed ID: 30321591
[TBL] [Abstract][Full Text] [Related]
59. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
60. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens.
Ramamoorthy S; Sanakkayala N; Vemulapalli R; Duncan RB; Lindsay DS; Schurig GS; Boyle SM; Kasimanickam R; Sriranganathan N
Int J Parasitol; 2007 Nov; 37(13):1521-9. PubMed ID: 17568587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
